Fibronostics’ cover photo
Fibronostics

Fibronostics

Hospitals and Health Care

Orlando, Florida 3,166 followers

An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.

About us

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics' LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics' HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients' risk levels and drive better patient care.

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Orlando, Florida
Type
Privately Held
Founded
2015
Specialties
liver, liver health, liver disease, nafld, artificial intelligence, machine learning, non invasive , nash, and med tech

Locations

  • Primary

    3452 Lake Lynda Dr

    Suite 151

    Orlando, Florida 32817, US

    Get directions
  • 79 Science Park Drive,Cintech IV

    #06-01/08

    Singapore, Singapore 118264, SG

    Get directions

Employees at Fibronostics

Updates

Similar pages